Compounds > 1,3-dipropyl-8-cyclopentylxanthine

1,3-dipropyl-8-cyclopentylxanthine and n-methyl-3,4-methylenedioxyamphetamine

1,3-dipropyl-8-cyclopentylxanthine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gossen, A; Harkin, A; Vanattou-Saïfoudine, N	1

Other Studies

1 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and n-methyl-3,4-methylenedioxyamphetamine

Article	Year
A role for adenosine A(1) receptor blockade in the ability of caffeine to promote MDMA "Ecstasy"-induced striatal dopamine release. European journal of pharmacology, 2011, Jan-10, Volume: 650, Issue:1 Topics: Adenosine A1 Receptor Antagonists; Animals; Caffeine; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Hypothalamus; In Vitro Techniques; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Xanthines	2011

Article

Year

A role for adenosine A(1) receptor blockade in the ability of caffeine to promote MDMA "Ecstasy"-induced striatal dopamine release.

European journal of pharmacology, 2011, Jan-10, Volume: 650, Issue:1

Topics: Adenosine A1 Receptor Antagonists; Animals; Caffeine; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Hypothalamus; In Vitro Techniques; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Xanthines

2011